Reply: Catecholamine-Mediated Pathways in Takotsubo Syndrome: Does it Matter If it Is a Serotonin Norepinephrine Reuptake Inhibitor or a Selective Serotonin Reuptake Inhibitor?

JACC Heart Fail. 2018 Aug;6(8):721-722. doi: 10.1016/j.jchf.2018.05.014.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Catecholamines
  • Heart Failure*
  • Humans
  • Norepinephrine
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin
  • Syndrome
  • Takotsubo Cardiomyopathy*

Substances

  • Catecholamines
  • Serotonin Uptake Inhibitors
  • Serotonin
  • Norepinephrine